Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

BACKGROUND: Metaplastic breast cancer remains poorly characterized given its rarity and heterogeneity. The majority of metaplastic breast cancers demonstrate a phenotype of triple-negative breast cancer; however, differences in clinical outcomes between metaplastic breast cancer and triple-negative...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Evan, Suresh, Anupama, Ganju, Akaansha, Stover, Daniel G., Wesolowski, Robert, Sardesai, Sagar, Noonan, Anne, Reinbolt, Raquel, VanDeusen, Jeffrey, Williams, Nicole, Cherian, Mathew A., Li, Zaibo, Young, Gregory, Palettas, Marilly, Stephens, Julie, Liu, Joseph, Luff, Amanda, Ramaswamy, Bhuvaneswari, Lustberg, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961248/
https://www.ncbi.nlm.nih.gov/pubmed/31937323
http://dx.doi.org/10.1186/s12957-019-1780-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961248/
https://www.ncbi.nlm.nih.gov/pubmed/31937323
http://dx.doi.org/10.1186/s12957-019-1780-8

Ejemplares similares